HAPTEN SCIENCES, INC.

Profile

Company Names

HAPTEN SCIENCES, INC.

Addresses

40 S. MAIN, SUITE 2200, MEMPHIS, TN 38103

40 SOUTH MAIN STREET, SUITE 2300, MEMPHIS, TN 38103

40 S. MAIN, SUITE 2300, MEMPHIS, TN 38103

Phone Numbers

9017473946
901-747-3946

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$5,881,948.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2019-10-21 
$885,980.00 
$1,500,000.00 
$614,020.00 
Debt 
6
2018-02-22 
$108,200.00 
$2,000,000.00 
$1,891,800.00 
Debt 
5
2018-01-30 
$1,587,768.00 
$2,200,000.00 
$612,232.00 
Debt 
4
2017-02-10 
$1,200,000.00 
$1,200,000.00 
$0.00 
Debt 
3
2015-09-03 
$1,225,000.00 
$1,725,000.00 
$500,000.00 
Debt 
2
2015-04-02 
$250,000.00 
$250,000.00 
$0.00 
Debt 
1
2013-05-13 
$625,000.00 
$1,200,000.00 
$575,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEPHEN 
I. 
BANDAK 
DIRECTOR
HAPTEN SCIENCES, INC.
STEPHEN 
L. 
BANDAK 
DIRECTOR
HAPTEN SCIENCES, INC.
RAYMOND 
J 
HAGE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
HAPTEN SCIENCES, INC.
RAYMOND 
J. 
HAGE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
HAPTEN SCIENCES, INC.
GARY 
 
PROSTERMAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
FOCAL POINT PHARMACEUTICALS, INC.   |  HAPTEN SCIENCES, INC.
GARY 
 
STEVENSON 
DIRECTOR
BIOSURFACE ENGINEERING TECHNOLOGIES INC   |  KEREOS, INC   |  RESTORE MEDICAL SOLUTIONS, INC.   |  SPINAL RESTORATION INC   |  HAPTEN SCIENCES, INC.   |  CAMPLEX, INC.   |  ORTHO KINEMATICS, INC.   |  CROSSROADS EXTREMITY SYSTEMS, LLC   |  SITE SAVER, INC.   |  FOCAL POINT PHARMACEUTICALS, INC.   |  STATERA SPINE, INC.   |  CRES HOLDINGS, INC.   |  CAST21, INC.
JOSEPH 
 
ZAKRZEWSKI 
DIRECTOR
PROMEDIOR INC   |  ZELOS THERAPEUTICS INC   |  XCELLEREX, INC.   |  AZELON PHARMACEUTICALS, INC.   |  THRASOS INNOVATION INC.   |  HAPTEN SCIENCES, INC.   |  SITEONE THERAPEUTICS, INC.   |  MACROLIDE PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2019-10-31
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2019-10-21 
2018-09-20
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-01-30 
2018-02-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-01-30 
2018-02-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2018-02-22 
2017-02-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-10 
2016-01-12
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-09-03 
2015-09-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-09-03 
2015-04-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-04-02 
2015-02-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-13 
2014-01-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NA
NONE